辉瑞第三季度营收166.5亿美元，预估165.9亿美元

Core Viewpoint - Pfizer reported an adjusted earnings per share of $0.87 for the third quarter and maintains its full-year revenue forecast of $61 billion to $64 billion [1] - The company has raised its full-year adjusted earnings per share guidance to $3.00 to $3.15, up from the previous estimate of $2.90 to $3.10 [1] - Following the earnings report, Pfizer's stock rose over 2% in pre-market trading [1] Financial Performance - Adjusted earnings per share for Q3 stood at $0.87 [1] - Full-year revenue forecast is set between $61 billion and $64 billion [1] - Adjusted earnings per share guidance for the full year has been increased to a range of $3.00 to $3.15 [1]